Benzinga's Top Initiations

By: via Benzinga
Analysts at Stifel Nicolaus initiated coverage on shares of Tekmira Pharmaceuticals (NASDAQ: TKMR ) with a “buy” rating. The target price for Tekmira Pharmaceuticals is set to $19. Tekmira's shares closed at $13.00 yesterday. Analysts at Wunderlich initiated coverage on shares of Gas Natural (NYSE: EGAS ) with a
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.